HOME Press Releases High-Resolution Melting Analysis Market worth 302.1 Million USD by 2021



High-Resolution Melting Analysis Market worth 302.1 Million USD by 2021


The report "High Resolution-Melting Analysis Market by Product (Supermix Reagent, RT PCR Instrument, Software), Application (SNP Genotyping, Mutation Discovery, Epigenetics), Enduser (Research Laboratories, Hospital, Diagnostic Center) - Global Forecast to 2021", report provides a detailed overview of the major drivers, restraints, and threat impacting the high-resolution melting analysis market along with the estimates and forecasts of the revenue and market share analysis.

Browse 78 market data tables and 57 figures spread through 143 pages and in-depth TOC on "High Resolution-Melting Analysis Market by Product (Supermix Reagent, RT PCR Instrument, Software), Application (SNP Genotyping, Mutation Discovery, Epigenetics), Enduser (Research Laboratories, Hospital, Diagnostic Center) - Global Forecast to 2021"
https://www.marketsandmarkets.com/Market-Reports/high-resolution-melting-analysis-market-216456020.html
Early buyers will receive 10% customization on reports.

The global high-resolution melting analysis market is expected to reach USD 302.1 Million by 2021 from USD 259.4 Million in 2016, at a CAGR of 3.1% during the forecast period of 2016 to 2021. Rising prevalence of infectious diseases and genetic disorders; increasing public-private investments, funds, and grants for research on genetic analysis technologies; and advantages of HRM over other genotyping technologies are the major factors driving market growth.

On the basis of product & service, the high-resolution melting analysis market is segmented into instruments, reagents & consumables, and software & services. The reagents and consumables segment dominated the market in 2016; and is expected to continue to dominate the market during the forecast period. The segment is also expected to grow at the highest CAGR during the forecast period.

On the basis of application, the high-resolution melting analysis market is broadly classified into SNP genotyping, mutation scanning, species identification, pathogen identification, epigenetics, and other applications. In 2016, the SNP genotyping segment accounted for the largest share of the high-resolution melting analysis market. This can be attributed to the wide range of applications of SNP genotyping in the diagnosis of genetic and autoimmune diseases, study of the variations in drug responses, drug discovery & development, and the identification of genetic variations in plant or animal genomes.

On the basis of end user, the high-resolution melting analysis market is segmented into research laboratories & academic institutes, hospitals & diagnostics centers, pharmaceutical & biotechnology companies, and other end users. In 2016, the research laboratories & academic institutes segment accounted for the largest share of the global high-resolution melting analysis market. This can be attributed to growing industry-academia collaborations in the field of qPCR-based genomic research, increasing government support for genome-based research (particularly in disease therapies and drug discovery), and the development of cost-effective and innovative qPCR products.

On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and RoW. In 2016, North America (comprising the U.S. and Canada) accounted for the largest share of the global high-resolution melting analysis market, followed by Europe. The rising prevalence of infectious diseases, genetic disorders, & other chronic diseases, and the large number of genotyping-based research and development projects are key growth drivers for the HRM market in North America.

Prominent players in the global high-resolution melting analysis market include Thermo Fisher Scientific Inc. (U.S.), F. Hofmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories (U.S.), and QIAGEN N.V. (Netherlands), Agilent Technologies Inc. (U.S.), bioMérieux S.A. (France), Illumina, Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Novacyt (France), Azura Genomics (U.S.), Canon Biomedical (U.S.), and PREMIER Biosoft (U.S.), among others.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports